Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV

Kamkwalala, Asante R.; Wang, Kunbo; O’Halloran, Jane A.; Williams, Dionna W.; Dastgheyb, Raha; Fitzgerald, Kathryn C.; Spence, Amanda B.; Maki, Pauline M.; Gustafson, Deborah; Milam, Joel; Sharma, Anjali; Weber, Kathleen M.; Adimora, Adaora A.; Ofotokun, Igho; Sheth, Anandi N.; Lahiri, Cecile D.; Fischl, Margaret A.; Konkle‐Parker, Deborah; Xu, Yanxun; Rubin, Leah H.

doi:10.1007/s10461-020-02967-2

Cited by 5 publications

(2 citation statements)

References 65 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The correlation between DTG and anxiety and depression is well-known, with several studies reporting anxiety and depressive manifestations that arose following the start of a DTG-containing regimen and regressed after discontinuation [ 41 – 43 ], even if the evidence is conflicting [ 44 ]. Regarding the association between Dolutegravir and PTSD, in contrast to our findings, a study carried out on over 500 women with HIV did not show a correlation between worsening of PTSD scores following the start or switch to therapy with Dolutegravir, while a worsening was found following a switch to therapy containing Raltegravir [ 45 ]. The mechanisms by which DTG can cause psychiatric disorders are not known, but the available studies suggest a multifactorial genesis that also includes genetic factors [ 46 ].…”

Section: Discussioncontrasting

confidence: 99%

Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study

Di Gennaro,

Papagni,

Segala

et al. 2024

BMC Infect Dis

View full text Add to dashboard Cite

Background Mental health (MH) is extremely relevant when referring to people living with a chronic disease, such as people living with HIV (PLWH). In fact – although life expectancy and quality have increased since the advent of antiretroviral therapy (ART) – PLWH carry a high incidence of mental disorders, and this burden has been exacerbated during the COVID-19 pandemic. In this scenario, UNAIDS has set new objectives for 2025, such as the linkage of at least 90% of PLWH to people-centered, context-specific MH services. Aim of this study was to determine the prevalence of MD in PLWH followed at the Clinic of Infectious Diseases of the University of Bari, Italy. Methods From January 10th to September 10th, 2022, all PLWH patients accessing our outpatient clinic were offered the following standardized tools: HAM-A for anxiety, BDI-II for depression, PC-PTSD-5 for post-traumatic stress disorder, CAGE-AID for alcohol-drug abuse. Factors associated with testing positive to the four MD were explored with a multivariable logistic regression model. Results 578 out of 1110 HIV-patients agreed to receive MH screening, with 141 (24.4%) people resulting positive to at least one MH disorder. HAM-A was positive in 15.8% (n = 91), BDI-II in 18% (n = 104), PC-PTSD-5 in 5% (n = 29) and CAGE in 6.1% (n = 35). The multivariable logistic regression showed a higher probability of being diagnosed with anxiety, depression and post-traumatic stress disorder for PLWH who reported severe stigma, social isolation, psychological deterioration during the COVID-19 pandemic and for those receiving a dolutegravir (DTG)-based regimen. Moreover, history of drug use (OR 1.13; [95% CE 1.06–4.35]), family stigma (2.42 [1.65–3.94]) and social isolation (2.72 [1.55;4.84]) were found to be associated to higher risk for substance use disorder. Conclusions In this study, stigma was a strong predictor for being diagnosed of a MH disorder among PLWH. Also, the possible role of dolutegravir as a risk factor for the onset of MH disorders should be considered in clinical practice, and MH of patients receiving DTG-containing regimens should be constantly monitored.

show abstract

Section: Discussioncontrasting

confidence: 99%

Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study

Di Gennaro,

Papagni,

Segala

et al. 2024

BMC Infect Dis

View full text Add to dashboard Cite

show abstract

“…44 In contrast, it is possible that long-term exposure to certain ART drugs may cause chronic CNS toxicity. [45][46][47] For example, a clinicopathologic study of PWH demonstrated that darunavir or ritonavir use was associated with higher likelihood of cerebral degenerative changes, such as neuronal phospho-tau lesions and marked microgliosis in the putamen. 46 Human herpes viruses are another possible contributor to excessive risk in PWH.…”

Section: Discussionmentioning

confidence: 99%

Dementias Among Older Males and Females in the U.S. Medicare System With and Without HIV

Kuo

Raji

et al. 2023

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

show abstract

Analysis of antiretroviral therapy interruption in people living with HIV during the 2010–2021 period

Contreras-Macías,

Gutiérrez-Pizarraya,

Pineda-Vergara

et al. 2024

Farmacia Hospitalaria

View full text Add to dashboard Cite

Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV

Cited by 5 publications

References 65 publications

Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study

Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study

Dementias Among Older Males and Females in the U.S. Medicare System With and Without HIV

Analysis of antiretroviral therapy interruption in people living with HIV during the 2010–2021 period

Contact Info

Product

Resources

About